IOVA FY 2017 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$952,000

Operating Income

-$93M

Net Income

-$92M

EPS (Diluted)

$-1.41

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$80M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$155M

Total Liabilities

$10M

Stockholders' Equity

$145M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$952,000	-$978,000	+2.7%
Operating Income	-$93M	-$54M	-73.2%
Net Income	-$92M	-$53M	-74.1%